Community

23-apr-2025 Novo Nordisk will face competition in the obisitas and diabetes space. Regulation and insurances may impact its growth.

Paysauce is finally hitting its stride - now being profitable and showing 32% revenue growth YoY (2023-24) along with the other following Q3 highlights reported January 14th 2025: ARR of $9.1m (Up 11% YoY) Recurring revenue of $2.3m for the quarter (Up 14% YoY) Processing fee revenue of $1.7m for the quarter (Up 19% YoY) Customers at end of the quarter: 8,127 (Up 11% YoY) One can only conclude that the continued growth will continue through 2025 and beyond as interest rates reduce further and the economy restabilises affecting growth within the overall SME market across NZ and other key asia-pac markets. Debt is still low and barely reportable through mainstream channels.

this one is after delete

Huntington Bancshares (HBAN) is currently trading around $14.56, with analysts offering a consensus 12-month price target of $15.59, suggesting a potential upside of around 7%. The stock has been rated as a "Moderate Buy" by most analysts, with 12 out of 19 giving it a "Buy" or "Strong Buy" recommendation.

Risks Dividend history is unstable Stock underperformed vs. industry and market in the past year Highly cyclical business – earnings depend heavily on commodity prices Catalysts Global demand for copper , especially from EVs, AI, and green infrastructure Grasberg mine in Indonesia and large-scale U.S. operations (e.g., Morenci, Bagdad) U.S. legislation may classify copper as a "critical mineral" , possibly introducing 10% tax credit Assumptions Where do you think revenue will be in 5 years time?

When looking at the earnings release, we could see that the company has been benefitting from record Data Center adoption. its revenue grew by 23% compared to the fourth quarter and 427% from a year ago it is fueled by strong and accelerating demand for generative AI training and inference Generative AI has expanded to consumer internet companies, and enterprise, sovereign AI, automotive and healthcare customers, creating multiple multibillion-dollar vertical markets Moreover, the company decided to announce a series of rewards for investors 10 for 1 forward stock split result in a proportionate increase in the number of shares of authorised common stock increasing its quarterly cash dividend by 150% from $0.04 per share to $0.10 per share of common stock

--- Vizsla Resources: Stock Price Estimate at $100 Silver Step 1: Future Revenue - Projected Resource: 275M oz AgEq. - Predicted Silver Price: $100/oz. - Revenue = 275,000,000 × 100 = $27,500,000,000 USD.

Recent development -USA tariff effect Analysis for brown and company and browns investments (browns and co. holds a little over 63% of browns investments) Browns investments plc acquired 100% ownership of Lipton Teas and Infusions Rwanda Limited and Tanzania Limited, along with 98.56% of Lipton Teas and Infusions Kenya Plc and 51.99% of Limura Tea Plc making it the largest tea producer in the world.

Increasing subscriber numbers alongside increasing ARPU yields 20% annual revenue growth as more and more businesses turn to cloud based accounting solutions with strong integrations and eventual AI features to run their businesses. Xero has high scalability of its products, with current gross margin of ~88%.